Company Filing History:
Years Active: 2005-2009
Title: Hishani Parbaharan: Innovator in Therapeutic Compounds
Introduction
Hishani Parbaharan is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds. With a total of 3 patents, his work focuses on innovative solutions for various health conditions.
Latest Patents
Parbaharan's latest patents include the development of therapeutic morpholino-substituted compounds. These compounds, specifically morpholino-substituted pyridopyrimidine, quinolone, and benzopyranone derivatives, inhibit phosphoinositide (PI) 3-kinase. This enzyme plays a crucial role in regulating platelet-adhesion processes. The inhibition of PI 3-kinase leads to anti-thrombotic activity and other pharmaceutical properties. The compounds are represented by formulas (I), (II), and (III). They are particularly useful in treating PI 3-kinase-dependent conditions, including cardiovascular diseases, respiratory diseases, inflammatory disorders, neoplasms, and diseases linked to disordered white blood cell function.
Career Highlights
Throughout his career, Hishani Parbaharan has worked with prominent companies such as AstraZeneca and Kinacia Pty. Ltd. His experience in these organizations has contributed to his expertise in the pharmaceutical industry.
Collaborations
Parbaharan has collaborated with notable colleagues, including Alan Duncan Robertson and Shaun P Jackson. These partnerships have further enhanced his research and development efforts in therapeutic innovations.
Conclusion
Hishani Parbaharan is a distinguished inventor whose work in therapeutic compounds has the potential to impact various medical fields significantly. His innovative approach to addressing complex health issues showcases the importance of research and development in the pharmaceutical industry.